Moreover, immunohistochemical analysis of 159 stage I-IV CRC samples, 32 polyps, and 238 normal samples showed a loss of FXR expression in the majority (94%) of CRC samples, and a marked reduction in FXR expression in precancerous polyps, compared with normal colon tissues. The gene discussed is NR1H4; the disease is colorectal carcinoma.